Montelukast Sodium Market size is forecast to reach $856 million by 2025, growing at a CAGR of 7.2% during the forecast period 2020-2025. Montelukast Sodium is used to treat asthma and seasonal year-round allergies. An increasing number of asthma patients and increasing prevalence of seasonal allergies also known as seasonal allergic rhinitis or hay fever are the major factors driving the growth of the market. The rise in respiratory diseases coupled with the growing geriatric population is set to further enhance the overall market demand of Montelukast Sodium during the forecast period 2020-2025. 

Key Takeaways

North America dominated the Montelukast Sodium Market in 2019 owing to the high prevalence of asthma and other respiratory diseases. The Montelukast Sodium Market scope for different regions will be provided in the final report.
Increasing prevalence of allergic diseases and its usage to prevent bronchospasm is likely to aid in the market growth of montelukast sodium.
Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Montelukast Sodium Market report.
Lack of awareness among people and increasing side effects such as stomach pain, heartburn, nausea, and diarrhea is poised to create hurdles for the Montelukast Sodium Market.

Application - Segment Analysis

Allergic Rhinitis segment held the largest share in the Montelukast Sodium Market in 2019. Allergic Rhinitis is also known as hay fever which is a type of inflammation in the nose. It is typically triggered by environmental allergens such as pollen, pet hair, dust, or mold. Inherited genetics and environmental exposures contribute to the development of allergies. Urticarial, also known as hives is an outbreak of swollen, pale red bumps or plaques on the skin that appear suddenly - either as a result of the body's reaction to certain allergens or for unknown reasons. It usually causes itching, but also burn or sting. In patients with angioedema predominant chronic spontaneous urticarial, the addition of the leukotriene receptor antagonist montelukast to background daily antihistamine therapy was done to improve symptoms in a significant proportion of individuals.

Drivers – Montelukast Sodium Market    

Rising respiratory diseases and increasing geriatric population
Increasing prevalence of allergic diseases and rapidly increasing urbanization

Montelukast Sodium, the top 10 companies are Apotex Corp, Glenmark Generic Ltd, Kudco Ireland Ltd, Merck Sharp Dohme Corp, Morepen Laboratory, Mylan N V, Roxane Laboratories, Inc, Sandoz International, Teva Pharmaceutical Industry Ltd, and Vintage Pharmaceutical Inc among others.

About IndustryARC : IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to [email protected] to discuss more about our consulting services.